“The Life Sciences, Biosecurity, and Dual Use Research” Designed by: Brian Rappert Malcolm Dando University of Exeter Bradford University Marie Chevrier.

Slides:



Advertisements
Similar presentations
HELPING THE NATION SPEND WISELY Performance audit and evaluation: common ground with Internal Audit ? The UK National Audit Office experience Jeremy Lonsdale.
Advertisements

Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Microbiology Bio 225L. CHAPTER 1 WHAT IS MICROBIOLOGY AND WHY IS IT IMPORTANT?
“Recruiting Norbiton’s Community Panel” Mike D’Souza.
Outline Introduction to the National Institutes of Health Office of Biotechnology Activities History and Evolution of IBCs: Asilomar to the Present Overview.
Bioterrorism: Changing Priorities in Medical Training and Research Richard Coico Professor and Chairman Department of Microbiology & Immunology City University.
Brian J. Gorman, M.Sc., J.D. Towson University, Maryland Presentation for The National Academies’ Committee on Scientific Communication and National Security.
Awareness and Education About the BTWC Professor Malcolm Dando University of Bradford UK.
DUAL USE RESEARCH OF CONCERN US Government (USG) Policy for Institutional Oversight of Life Sciences 10/13/2014.
1 The Basic Problem: Dual-Use Research Kathryn Nixdorff Department of Microbiology and Genetics Darmstadt University of Technology, Germany.
Use of Children as Research Subjects What information should be provided for an FP7 ethical review?
The International Regulation of Biotechnology Lecture No. 19 Further Inf. For further information and video link please click on the right buttons in the.
Addressing Synthetic Biology and Biosecurity
Dual-Use: The Fink Report
The Select Agent Laboratory: at the intersection of research, preparedness and safety Nancy Connell,PhD Professor and Vice-chair for Research Department.
Draft Lecture No 14 By Malcolm Dando. I. Outline The concept of dual-use Slides The Fink Committee Report –A. Objective and structure of the report.
The Growth of Dual-Use Bioethics Lecture No.13 Further Inf. For further information and video link please click on the right buttons in the following slides.
1 Scientific Responsibility in an Age of Terrorism: Codes of Conduct for the Bioscience/medical Community Brian Rappert & Malcolm Dando.
1 Ethics in Psychological Research  Ethics – __________________  Research ethics – responsibility of researchers to be honest and respectful of all individuals.
Overview of the Lectures in the Education Module Resource Lecture No. 1.
The New Inter-Sessional Process of the BTWC 2007 – 2010 Lecture No. 10.
Infectious Diseases Unit 5 Lesson 5 plan.
Frequently Asked Questions (FAQ) prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
AAA 3102 RESEARCH METHODOLOGY Lecture 2 The Research Process & Literature Review.
Selecting Researchable Topics and Questions
GENETICALLY MODIFIED ORGANISM PRESENTATION 13 September 2013 By Department of Trade and Industry.
Copyright © 2006 Pearson Education, Inc. publishing as Benjamin Cummings PowerPoint® Lectures Lectures by Chris Romero, Front Range Community College Pandora’s.
Involving the Whole Organization in Creating or Restructuring a Volunteer Program Louise DeIasi DeCava Consulting.
Merging university departments, schools and faculties Piers Brissenden School of Health Sciences University of South Australia.
Advocacy in Science: Opportunities, Limits, Responsibilities and Risks FASEB: A Public Policy Voice for Biological and Biomedical Researchers Howard Garrison.
Director, DG RTD, Directorate International Cooperation
DUAL USE BIOETHICS AND LIFE SCIENTISTS EDUCATION IN UKRAINE: FOCUS ON NEUROSCIENCE Olena Kysil Palladin Institute of Biochemistry of the National Academy.
RS–IAP-ICSU, September 2006 NSABB National Science Advisory Board on Biosecurity Dual Use Research: Scope, Criteria and Communication.
Dual-Use Research: A Double Challenge for International Science Henry Metzger, MD Scientist Emeritus, NIAMS, NIH.
Guidance for AONB Partnership Members Welsh Member Training January 26/
Responsible Stewardship: Choices and Challenges in Preventing the Malign Use of the Life Sciences Brian Rappert.
Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee.
BSAF-BIONET Meeting Robert J. Hashimoto, CBSP University of California, Berkeley October 2, 2009.
Perspectives on the Sharing of Research Materials and Data Reid Adler Founder and Principal, Practical Innovation Strategy Washington, DC Presentation.
Dual Use Research of Concern Boston University and Boston Medical Center.
Excellence in science The Royal Society is the independent scientific academy of the UK dedicated to promoting excellence in science. Royal Society’s work.
United States Army Medical Research Institute of Infectious Diseases KYLE MELLING.
Dual Use Research of Concern (DURC) University of North Carolina at Greensboro.
Biosafety and Bioethics Dr. Sarah bukhari Ass.Prof. pharmaceutical microbiology.
Public Health Preparedness Summer Institute for Public Health Practice August 4, 2003.
Governor’s Taskforce for Pandemic Influenza Preparedness Issue Paper Credible and Effective Decision-making Workgroup Members Robert Rolfs, State Epidemiologist,
DEVELOPMENTS CONCERNING SECRECY IN UNIVERSITY RESEARCH Dave Broome Sr. Associate General Counsel NC State University.
World Health Organization Life science research: opportunities and risks for public health Ottorino Cosivi Department of Epidemic and Pandemic Alert and.
Controlling Dangerous Pathogens Elisa D. Harris Center for International and Security Studies at Maryland BWC Meeting of Experts Geneva, 19 August 2003.
Mid – Late 1970’s Emergence of recombinant DNA technology Concerns among both scientific community and general public:  Public health and safety  Environmental.
Dual Use Research, Bioweapons and Biosecurity Iris Hunger Research Group for Biological Arms Control Carl Friedrich von Weizsäcker Centre for Science and.
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS.
Royal Irish Academy Briefing Bert Rima 109/01/2016.
UNDERSTANDING BIOTERRORISM: Tara O’Toole, MD, MPH The United States Conference of Mayors Mayors Emergency, Safety & Security Summit October 24, 2001.
Understanding Animal Welfare Issues. Next Generation Science/Common Core Standards Addressed! RST.9 ‐ 10.8 Assess the extent to which the reasoning and.
"When does new science become a threat?".. problem - experimentation - discovery The scientific process.
1 The Argument for Oversight: Developments in the US John Steinbruner University of Maryland Controlling Dangerous Pathogens Project: Regional Workshop.
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
PP 620: Public Policy and Health Administration Unit One Seminar Kris R. Foote, J.D., M.P.A., M.S.W. Kaplan University.
Genome editing: What lessons can we learn from the mitochondrial donation debate? Peter Thompson Human Fertilisation & Embryology Authority.
Equipping the Next Generation for Active Engagement in Science EngagingScience.eu שילוב נושאים סוציו-מדעיים ואתיים בלימודי מדע ד"ר יעל שורץ, אתי דגן ואמיל.
For more course tutorials visit
Stanford University Dual Use Research of Concern in the Life Sciences
Biosafety at Swinburne
13 September 2013 By Department of Trade and Industry
The NICE Citizens Council and the role of social value judgements
Quality Risk Management ICH Q9 Frequently Asked Questions (FAQ)
Presentation transcript:

“The Life Sciences, Biosecurity, and Dual Use Research” Designed by: Brian Rappert Malcolm Dando University of Exeter Bradford University Marie Chevrier University of Texas at Dallas

Project on Dual Use Research in Life Sciences Increased concern about bioterrorism and biowarfare amongst policy makers following 9/11 and anthrax letter attacks Discussions about the potential for misuse of biological research and how to prevent it Seminar Objective: to encourage an interactive discussion amongst practising scientists and students about the possible malign misuse of the life sciences

Playing Your Role Powerpoint slides will address relevant issues in dual-use research and ask questions. First respond from the perspective of your character. Try to understand the reasons a person might hold these views and the implications of such an opinion. If you wish you may state your own views if they differ from that of your character.

Communication The first set of slides concern the communication of research results. The publication of certain dual use research results have provoked recent discussions about potential misuse.

Australian Mousepox Experiment An Example of Dual-Use Research Plagues of hundreds of millions of mice cause millions of dollars of damage in Australia’s grain belt. To prevent or mitigate such plagues Australian researchers try to induce sterility in mice by altering an infectious virus that affects mice: mousepox. They insert egg protein gene into mousepox genome to create antibody response against eggs and thus rejection. They also insert the IL-4 gene to enhance the antibody response.

Communication Questions The researchers produced a recombinant virus with greatly increased lethality. The virus with IL-4 killed mice genetically resistant to mousepox and those immunized against it. Concerns arise because of the potential for increased lethality of other pox viruses, including smallpox. Published in Journal of Virology Feb Do you agree with the decision to publish? If so, why? If not, why not? What follows on from your views?

Another Kind of Communication January 2001Australian researchers worked with a popular magazine to publish a preview of their paper. New Scientist published an article with the following title: “Disaster in the Making: An engineered mouse virus leaves us one step away from the ultimate bioweapon” How do you view the decision to popularly publish (why, what follows on from this, etc.)? Rationale: "We wanted to warn the general population that this potentially dangerous technology is available…We wanted to make it clear to the scientific community that they should be careful, that it is not too difficult to create severe organisms." -- R. Jackson

Another Model for Communication Suggestion that British researchers had previously obtained similar results to the Australian mousepox research. The researchers were said to have informed Health and Safety Executive, but deliberately avoided discussing or alluding to bioweapons implications in their publication. A literature search revealed a 1998 Journal of Virology article that might be research in question: –IL-4 insertion in modified vaccinia virus (VRBm) –“A mortality of 100% was observed for mice immunized with VRBmIL-4 [modified vaccinia with IL-4 gene]… This contrasted with that for mice immunized with rVV expressing low levels of IL-4…which showed no ill effects…” What are the merits of this “softly-softly” approach?

Funding Ideas of restricting research and publications are generally treated as matters of concern by practicing life scientists. However, the funding of various lines of research has also provoked discussions of interest in relation to dual use research.

What is Being Funded: Keeping Ahead Through Research US Program: “Biodefense for the 21st Century” NIH biodefense research~$50million (2001) ~$1.6 billion (2005) National Institute of Allergy and Infectious Diseases in 2005 roughly 190 research awards about therapeutics, diagnostics, host response, vaccines, basic biological mechanisms 13 BSL-3 and 7 BSL-4 research facilities under construction Other civilian programs under Department Health and Human Services, Departments of Agriculture, Homeland Security, etc. totalling ~$3.4 billion (2006) for research programs and facilities Is this to be welcomed and why?

Oversight As concerns about the possible misuse of research have grown, attention has increasingly focused on whether new forms of oversight of research are required. The final set of slides address this issue.

Development of Biosafety Oversight In 1970’s life scientists began to manipulate genomes. Many countries have instituted review procedures to ensure biosafety of such experiments. In US, Asilomar Conference in 1975 led to NIH funded research subject to rDNA review procedures. James Watson and Sydney Brenner at Asilomar

US National Academies Fink Report “Biotechnology Research in an Age of Terrorism” Expand existing local and national biosafety review for NIH funded rDNA research to include biosecurity. Apply new procedures to ‘experiments of concern’ in US e.g.: –Making vaccines ineffective –Altering host range or enhancing virulence of pathogens –Conferring resistance to useful antibiotics or antivirals Establish National Science Advisory Board for Biosecurity to: review, survey and educate bioscientists including to ‘develop guidelines for the oversight of dual-use research, including guidelines for the risk/benefit analysis...’ Are biosecurity oversight mechanisms to be welcomed? Why or why not?

What Else Might be Done If Fink recommendations not welcomed, what about… “We’re looking for the scientific community to come forward itself because the government will not do this very efficiently and not do it very well at all. We are looking for scientific community to come forward to help establish these kinds of criteria [for the oversight of research], to debate them openly.” -- Penrose Albright (2003) Office of Homeland Security White House Office of Science & Technology Policy

What Else Might be Done? “Protective Oversight System” Former government officials now at University of Maryland and an international team developed a legally based system. Three-tiered categorization based on potential consequences: –International oversight of extremely dangerous research = greater than currently active agents. –National oversight of moderately dangerous research = the worst of the current select agents. –Local oversight of potentially dangerous research = agents that might be elevated to moderate or extreme categories by use of advanced manipulation techniques

“Protective Oversight System” cont. Mandatory for all relevant facilities including: –Military –Commercial –Government –Academic Require licensing of facilities and researchers on biosecurity grounds including background checks and training Is this type of oversight system to be welcomed? Why or why not? Implications?

Weighing the Risks and Benefits In 2003 thirty-two scientific journals (ASM journals, Science, Nature) agreed on a process for reviewing, modifying, and perhaps even rejecting research articles where ‘the potential harm of publication outweighs the potential societal benefits.’ UK Wellcome Trust has taken dual-use potential of research into account in reviewing proposals

Results of Applying Risk/Benefit Analysis No publication yet stopped in any journals; though two were modified. Wellcome Trust never refused an application or imposed publication restrictions because of dual use concerns ‘Extreme’ case: 2005 Sequencing and reconstruction of 1918 Spanish Flu virus: NSABB, Science, Nature agree benefits outweighed the risk Will the risks ever outweigh the benefits?

Thank You & Debrief

Debriefing the Role Play What role did you find yourself identifying with most strongly? Why? What aspects of the role assigned to you did you find easiest to present? What aspects of the role assigned to you did you find most difficult to present? Do you have additional arguments, insights or opinions that were not represented by people playing the other roles?